Form EFFECT Fortress Biotech, Inc.
Tweet
Share
E-mailGet instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 1, 2021 |
| Accession Number: | 0001104659-21-143552 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Checkpoint Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
- Cantor Fitzgerald Reiterates Overweight Rating on Fortress Biotech (FBIO) on Q1 Report, "Risk-Diversification Remains Attractive "
- VSBLTY REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
